CD40L-deficient mice show deficits in antiviral immunity and have an impaired memory CD8+ CTL response

Journal of Experimental Medicine

Volumn 183, Issue 5, 1996, Pages 2129-2142

  Borrow, Persephone ^a   Tishon, Antoinette ^a   Lee, Sherina ^a   Xu, Jianchao ^b   Grewal, Iqbal S ^b   Oldstone, Michael B A ^a   Flavell, Richard A ^b  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANTIGEN SPECIFICITY; ANTIVIRAL ACTIVITY; ARTICLE; GENE TARGETING; IMMUNE RESPONSE; LIGAND BINDING; MEMORY; MEMORY CELL; MOUSE; NONHUMAN; OVARY FOLLICLE CELL; PRIORITY JOURNAL; VIRUS INFECTION; VIRUS MENINGITIS;

ANIMALS; ANTIBODIES, VIRAL; ANTIBODY FORMATION; ANTIGENS, CD40; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; CD40 LIGAND; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOLOGIC MEMORY; IMMUNOTHERAPY, ADOPTIVE; MEMBRANE GLYCOPROTEINS; MICE; MICE, KNOCKOUT; REFERENCE VALUES; RHABDOVIRIDAE INFECTIONS; SPLEEN; T-LYMPHOCYTES, CYTOTOXIC; THYMUS GLAND; VESICULAR STOMATITIS-INDIANA VIRUS;

EID: 0029890580     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.183.5.2129     Document Type: Article

References (61)

1. Armitage, R.J., W.C. Fanslow, L. Stockbine, T.A. Sato, K.N. Clifford, B.M. Macduff, D.M. Anderson, S.D. Gimpel, T. Davis-Smith, C.R. Maliszewski et al. 1992. Molecular and biological characterization of a murine ligand for CD40. Nature (Lond.). 357:80-82.
2. Hollenbaugh, D., L. Grosmaire, C.D. Kullas, N.J. Chalupny, R.J. Noelle, I. Stamenkovic, J.A. Ledbetter, and A. Aruffo. 1992. The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of gp39 with B cell co-stimulatory activity. EMBO (Eur. Mol. Biol. Organ.) J. 11:4313-4321.
3. Roy, M., T. Waldschmidt, A. Aruffo, J.A. Ledbetter, and R.J. Noelle. 1993. The regulation of the expression of gp39, the CD40 ligand, on normal and cloned CD4+ T cells. J. Immunol. 151:2497-2510.
4. Lane, P., A. Traunecker, S. Hubele, S. Inui, A. Lanzavecchia, and D. Gray. 1992. Activated human T cells express a ligand for the human B cell-associated antigen CD40 which participates in T cell-dependent activation of B lymphocytes. Eur. J. Immunol. 22:2573-2578.
5. Van den Eertwegh, A.J.M., R.J. Noelle, M. Roy, D.M. Shepherd, A. Aruffo, J.A. Ledbetter, W.J.A. Boersma, and E. Claassen. 1993. In vivo CD40-gp39 interactions are essential for thymus-dependent immunity. I. CD40-gp39 interactions are essential for thymus-dependent humoral immunity and identify sites of cognate interactions in vivo. J. Exp. Med. 178:1555-1565.
6. Spriggs, M.K., R.J. Armitage, L. Stockbine, K.Y. Clifford, B.M. Macduff, T.A. Sato, C.R. Maliszewski, and W.C. Fanslow. 1992. Recombinant human CD40 ligand stimulates B cell proliferation and immunoglobulin E secretion. J. Exp. Med. 176:1543-1550.
7. Lederman, S., M.J. Yellin, G. Inghirami, J.J. Lee, D.M. Knowles, and L. Chess. 1992. Molecular interactions mediating T-B lymphocyte collaboration in human lymphoid follicles: roles of T cell-B cell-activating molecule (5c8 antigen) and CD40 in contact-dependent help. J. Immunol. 149:3817-3826.
8. van Kooten, C., and J. Banchereau. 1996. CD40-CD40 ligand: a multifunctional receptor-ligand pair. Adv. Immunol. 61:1-77.
9. Noelle, R.J., M. Roy, D.M. Shepherd, I. Stamenkovic, J.A. Ledbetter, and A. Aruffo. 1992. A 39-kDa protein on activated helper T cells bind CD40 and transduces the signal for cognate activation of B cells. Proc. Natl. Acad. Sci. USA. 89: 6550-6554.
10. Notarangelo, L.D., M. Duse, and A.C. Ugazio. 1992. Immunodeficiency with hyper-IgM (HIM). Immunodef. Ref. 3:101-121.
11. Foy, T.M., A. Aruffo, J.A. Ledbetter, and R.J. Noelle. 1993. In vivo CD40-gp39 interactions are essential for thymus-dependent immunity. II. Prolonged in vivo suppression of primary and secondary humoral immune responses by an antibody targeted to the CD40 ligand, gp39. J. Exp. Med. 178: 1567-1575.
12. Foy, T.M., J.D. Laman, J.A. Ledbetter, A. Aruffo, E. Classen, and R.J. Noelle. 1994. gp39-CD40 interactions are essential for germinal center formation and the development of B cell memory. J. Exp. Med. 180:157-165.
13. Gray, D., P. Dullforce, and S. Jainandunsing. 1994. Memory B cell development but not germinal center formation is impaired by in vivo blockage of CD40-CD40 ligand interaction. J. Exp. Med. 180:141-155.
14. Foy, T.M., F.H. Durie, and R.J. Noelle. 1994. The expansive role of CD40 and its ligand, gp39, in immunity. Semin. Immunol. 6:259-266.
15. Grewal, I.S., J. Xu, and R.A. Flavell. 1995. Impairment of antigen-specific T cell priming in mice lacking CD40 ligand. Nature (Lond.). 378:617-620.
16. Xu, J., T.M. Foy, J.D. Lamar, E.A. Elliott, J.J. Dunn, T.J. Waldschmidt, J. Elsemore, R.J. Noelle, and R.A. Flavell. 1994. Mice deficient for the CD40 ligand. Immunity. 1:423-431.
17. Renshaw, B.R., W.C. Fanslow III, R.J. Armitage, K.A. Campbell, D. Liggitt, B. Wright, B.L. Davison, and C.R. Maliszewski. 1994. Humoral immune responses in CD40 ligand-deficient mice. J. Exp. Med. 180:1889-1900.
18. Byrne, J.A., and M.B.A. Oldstone. 1984. Biology of cloned cytotoxic T lymphocytes specific for LCMV: clearance of virus in vivo. J. Virol 51:682-686.
19. Ahmed, R., B.D. Jamieson, and D.D. Porter. 1987. Immune therapy of a persistent and disseminated viral infection. J. Virol. 61:3920-3929.
20. + T lymphocytes mediate clearance of virus and regulate the antiviral antibody response. J. Virol. 61:1867-1874.
21. Fung-Leung, W.-P., T.M. Kündig, R.M. Zinkernagel, and T.W. Mak. 1991. Immune response against lymphocytic choriomeningitis virus infection in mice without CD8 expression. J. Exp. Med. 174:1425-1429.
22. Lefrancois, L., and D.A. Lyles. 1982. The interaction of antibody with the major surface glycoprotein of vesicular stomatitis virus. I. Analysis of neutralizing epitopes with monoclonal antibodies. Virology. 121:157-167.
23. Le Francois, L. 1984. Protection against lethal viral infection by neutralizing and non-neutralizing monoclonal antibodies: distinct mechanisims of action in vivo. J. Virol. 51:208-214.
24. Steinhoff U., U. Müller, A. Schertler, H. Hengartner, M. Aguet, and R.M. Zinkernagel. 1995. Antiviral protection by vesicular stomatitis virus-specific antibodies in alpha/beta interferon receptor-deficient mice. J. Virol. 69:2153-2158.
25. Dutko, F.J., and M.B.A. Oldstone. 1983. Genomic and biological variation among commonly used lymphocytic choriomeningitis virus strains. J. Gen. Virol. 64:1689-1698.
26. Buchmeier, M.J., and W.E. Rawls. 1977. Variation between strains of hamster: in the lethality of Pichinde virus infection. Infect. Immun. 16:413-421.
27. Buchmeier, M.J., and M.B.A. Oldstone. 1979. Protein structure of lymphocytic choriomeningitis virus: evidence for a cell-associated precursor of the virion glycopeptides. Virology. 99:111-120.
28. Burns, J.W., and M.J. Buchmeier. 1991. Protein-protein interactions in lymphocytic choriomeningitis virus. Virology. 183:620-629.
29. DePolo, N.S., C. Giachetti, and J.J. Holland. 1987. Continuing coevolution of virus and defective interfering particles and of viral genome sequences during undiluted passages: viral mutants exhibiting nearly complete resistance to formerly dominant defective interfering particles. J. Virol. 61:454-464.
30. Cobbold, S.P., A. Jayasuriya, A.A. Nash, T.D. Prospero, and H. Waldmann. 1984. Therapy with monoclonal antibodies by elimination of T cell subsets in vivo. Nature (Lond.). 312: 548-551.
31. Whitton, J.L., P.J. Southern, and M.B.A. Oldstone. 1988. Analyses of the cytotoxic T lymphocyte responses to glycoprotein and nucleoprotein components of LCMV. Virology. 162:321-327.
32. Whitton, J.L., N. Sheng, M.B.A. Oldstone, and T.A. McKee. 1993. A "string-of-beads" vaccine, comprising linked minigenes, confers protection from lethal-dose virus challenge. J. Virol. 67:348-352.
33. Whitton, J.L., and M.B.A. Oldstone. 1989. Class I MHC can present an endogenous peptide to cytotoxic T lymphocytes. J. Exp. Med. 170:1033-1038.
34. Ahmed, R., A. Salmi, L.D. Butler, J.M. Chiller, and M.B.A. Oldstone. 1984. Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice. Role in suppression of cytotoxic T lymphocyte response and viral persistence. J. Exp. Med. 60:521-540.
35. Slifka, M.K., M. Matloubian, and R. Ahmed. 1995. Bone marrow is a major site of long-term antibody production after acute viral infection. J. Virol. 69:1895-1902.
36. Borrow, P., C.F. Evans, and M.B.A. Oldstone. 1995. Virus-induced immunosuppression: Immune system-mediated destruction of virus-infected dendritic cells results in generalized immune suppression. J. Virol. 69:1059-1070.
37. Macchia, D., F. Almerigogna, P. Parronchi, A. Ravina, E. Maggi, and S. Romagnani. 1993. Membrane tumor necrosis factor-α is involved in the polyclonal B-cell activation induced by HIV-1-infected human T cells. Nature (Lond.). 363: 464-466.
38. Diaz-Sanchez, D., S. Chegini, K. Khang, and A. Saxon. 1994. CD58 (LFA-3) stimulation provides a signal for human isotype switching and IgE production distinct from CD40. J. Immunol. 153:10-20.
39. Life, P., J.-F. Gauchat, V. Schnuriger, S. Estoppey, G. Mazzei, A. Durandy, A. Fischer, and J.-Y. Bonnefoy. 1994. T cell clones from an X-linked hyper-immunoglobulin (IgM) patient induce IgE synthesis in vitro despite expression of nonfunctional CD40 ligand. J. Exp. Med. 180:1775-1784.
40. Armerding, D., F.C. van Reijsen, A. Hren, and G.C. Mudde. 1994. Induction of IgE and IgG1 in human B cell cultures with staphylococcal superantigens: role of helper T cell interaction, resistance to interferon-gamma. Immunobiology. 188:259-273.
41. Charan, S., and R.M. Zinkernagel. 1986. Antibody mediated suppression of secondary IgM response in nude mice against vesicular stomatitis virus. J. Immunol. 136:3057-3061.
42. Freer, G., C. Burkhart, I. Ciernik, M.F. Bachmann, H. Hengartner, and K.M. Zinkernagel. 1994. Vesicular stomatitis virus Indiana glycoprotein as a T cell-dependent and independent antigen. J. Virol. 68:3650-3655.
43. Leist, T.P., S.P. Cobbold, H. Waldmann, M. Aguet, and R.M. Zinkernagel. 1987. Functional analysis of T lymphocyte subsets in antiviral host defense. J. Immunol. 138:2278-2281.
44. Goodman-Snitkoff, G., R.J. Mannino, and J.J. McSharrey. 1981. The glycoprotein isolated from vesicular stomatitis virus is mitogenic for mouse B lymphocytes. J. Exp. Med. 153: 1489-1502.
45. Bachmann, M.F., U. Hoffmann Rohrer, T.M. Kündig, K. Bürki, H. Hengartner, and R.M. Zinkernagel. 1993. The influence of antigen organization on B cell responsiveness. Science (Wash. DC). 262:1448-1451.
46. Van den Eertwegh, A.J.M., J.D. Laman, R.J. Noelle, W.J.A. Boersma, and E. Claassen. 1994. In vivo T-B cell interactions and cytokine production in the spleen. Semin. Immunology. 6: 327-336.
47. Mond, J.J., A. Lees, and C.M. Snapper. 1995. T cell-independent antigens type 2. Annu. Rev. Immunol. 13:655-692.
48. Schreiber, R.D., L.J. Micks, A. Celada, N.A. Buchmeier, and P.W. Gray. 1985. Monoclonal antibodies to murine γ-interferon which differentially modulate macrophage activation and antiviral activity. J. Immunol. 134:1609-1618.
49. Gresser, I., M.G. Tovey, C. Maury, and M.-T. Bandu. 1976. Role of interferon in the pathogenesis of virus diseases as demonstrated by the use of anti-interferon serum II. Studies with herpes simplex, moloney sarcoma, vesicular stomatitis, Newcastle disease and influenza viruses. J. Exp. Med. 144: 1316-1323.
50. Müller, U., U. Steinhoff, L.F.L. Reis, S. Hemmi, J. Pavlovic, R.M. Zinkernagel, and M. Aguet. 1994. Functional role of type 1 and type II interferons in antiviral defense. Science (Wash. DC). 264:1918-1921.
51. Miyoshi, K., D.H. Harter, and K.C. Hsu. 1971. Neuropathological and immunofluorescence studies of experimental vesicular stomatitis virus encephalitis in mice. J. Neuropathol. Exp. Neurol. 31:266-277.
52. Tew, J.G., R.M. DiLosa, G.F. Burton, M.H. Kosco, L.I. Kupp, A. Masuda, and A.K. Szakal. 1992. Germinal centers and antibody production in bone marrow. Immunol. Rev. 126:99-112.
53. MacLennan, I.C.M., and D. Gray. 1986. Antigen-driven selection of virgin and memory B cells. Immunol. Rev. 91:61-85.
54. Liu, Y.J., D.E. Joshua, G.T. Williams, C.A. Smith, J. Gordon, and I.C. MacLennan. 1989. Mechanism of antigen-driven selection in germinal centers. Nature (Lond.). 342:929-931.
55. Wang, Z., J.G. Karras, R.G. Howard, and T.L. Rothstein. 1995. Induction of bcl-x by CD40 engagement rescues sIg-induced apoptosis in murine B cells. J. Immunol. 155:3722-3726.
56. Klavinskis, L.S., J.L. Whitton, and M.B.A. Oldstone. 1993. Molecular anatomy of the cytotoxic T lymphocyte responses to lymphocytic choriomeningitis virus. In The Arenaviridae, M. Salvato, editor. Plenum Press, New York. 225-246.
57. Lau, L.L., B.D. Jamieson, T. Somasundaram, and R. Ahmed. 1994. Cytotoxic T-cell memory without antigen. Nature (Lond.). 369:648-652.
58. + T-cell memory determined by clonal burst size. Nature (Lond.). 936:652-654.
59. + cells in sustaining lymphocyte proliferation during lymphocytic choriomeningitis virus infection. J. Immunol. 146:1955-1963.
60. + T-cell-deficient mice. J. Virol. 68:4700-4704.
61. von Herrath, M.G., M. Yokoyama, J. Dockter, M.B.A. Oldstone, and J.L. Whitton. 1996. CD4-deficient mice have reduced levels of memory CTL following immunization, and show diminished resistance to subsequent virus challenge. J. Virol. 70:1072-1079.